Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Spontaneous Coronary Artery Dissection - Antiplatelet Therapy Intensity in Guided Conservative Management (SCAD-ALIGN) Trial

NCT07683923 is registered in ClinicalTrials.gov with Universitätsklinikum Hamburg-Eppendorf as lead sponsor.

NCT NCT07683923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07683923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Spontaneous Coronary Artery Dissection - Antiplatelet Therapy Intensity in Guided Conservative Management (SCAD-ALIGN) Trial
Lead sponsor
Universitätsklinikum Hamburg-Eppendorf
Phase
Phase 4
Overall status
Not yet recruiting
Start date
March 1, 2027
Completion date
February 28, 2033
Enrollment
3,518 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

acs (acute coronary syndrome), scad